BCLAF1 Antikörper (AA 218-407) (FITC)
-
- Target Alle BCLAF1 Antikörper anzeigen
- BCLAF1 (BCL2-Associated Transcription Factor 1 (BCLAF1))
-
Bindungsspezifität
- AA 218-407
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCLAF1 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Bcl-2-associated transcription factor 1 protein (218-407AA)
- Isotyp
- IgG
- Top Product
- Discover our top product BCLAF1 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- BCLAF1 (BCL2-Associated Transcription Factor 1 (BCLAF1))
- Andere Bezeichnung
- BCLAF1 (BCLAF1 Produkte)
- Hintergrund
-
Background: Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3\'end of the CCND1 gene and its mRNA.
Aliases: Bcl 2 associated transcription factor antibody, Bcl-2-associated transcription factor 1 antibody, BCL2 associated transcription factor 1 antibody, BCLAF1 antibody, BCLF1_HUMAN antibody, bK211L9.1 antibody, Btf antibody, KIAA0164 antibody
- UniProt
- Q9NYF8
- Pathways
- Positive Regulation of Response to DNA Damage Stimulus
-